Skip to main content
Patient-Centered Outcomes Research Institute
Patient-Centered Outcomes Research Institute
  • Blog
  • Newsroom
  • Find It Fast
  • Help Center
  • Subscribe
  • Careers
  • Contact Us

PCORI

Patient-Centered Outcomes Research Institute

Search form

  • About Us
    Close mega-menu

    About Us

    • Our Programs
    • Governance
    • Financials and Reports
    • Procurement Opportunities
    • Our Staff
    • Our Vision & Mission
    • Contact Us

    Fact Sheets: Learn More About PCORI

    Download fact sheets about out work, the research we fund, and our programs and initiatives.

    Find It Fast

    Browse through an alphabetical list of frequently accessed and searched terms for information and resources.

    Subscribe to PCORI Email Alerts

    Sign up for weekly emails to stay current on the latest results of our funded projects, and more.

  • Research & Results
    Close mega-menu

    Research & Results

    • Explore Our Portfolio
    • Research Fundamentals
    • Research Results Highlights
    • Putting Evidence to Work
    • Peer Review
    • Evidence Synthesis
    • About Our Research

    Evidence Updates from PCORI-Funded Studies

    These updates capture highlights of findings from systematic reviews and our funded research studies.

    Journal Articles About Our Funded Research

    Browse through a collection of journal publications that provides insights into PCORI-funded work.

    Explore Our Portfolio of Funded Projects

    Find out about projects based on the health conditions they focus on, the state they are in, and if they have results.

  • Topics
    Close mega-menu

    Topics

    • Addressing Disparities
    • Arthritis
    • Asthma
    • Cancer
    • Cardiovascular Disease
    • Children's Health
    • Community Health Workers
    • COVID-19
    • Dementia and Cognitive Impairment
    • Diabetes
    • Intellectual and/or Developmental Disabilities
    • Kidney Disease
    • Maternal Morbidity and Mortality
    • Medicaid
    • Men's Health
    • Mental and Behavioral Health
    • Minority Mental Health
    • Multiple Chronic Conditions
    • Multiple Sclerosis
    • Obesity
    • Older Adults' Health
    • Pain Care and Opioids
    • Rare Diseases
    • Rural Health
    • Shared Decision Making
    • Telehealth
    • Transitional Care
    • Veterans Health
    • Women's Health

    Featured Topic: Women's Health

    Learn more about the projects we support on conditions that specifically or more often affect women.

  • Engagement
    Close mega-menu

    Engagement

    • The Value of Engagement
    • Engagement in Health Research Literature Explorer
    • Influencing the Culture of Research
    • Engagement Awards
    • Engagement Resources
    • Engage with Us

    Engagement Tools and Resources for Research

    This searchable peer-to-peer repository includes resources that can inform future work in patient-centered outcomes research.

    Engagement Awards

    Learn about our Engagement Awards program and view the announcements of all our open funding opportunities.

    Research Fundamentals: A New On-Demand Training

    It enables those new to health research or patient-centered research to learn more about the research process.

  • Funding Opportunities
    Close mega-menu

    Funding Opportunities

    • What & Who We Fund
    • What You Need to Know to Apply
    • Applicant Training
    • Merit Review
    • Awardee Resources
    • Help Center

    PCORI Funding Opportunities

    View and learn about the newly opened funding announcements and the upcoming PFAs in 2021.

    Tips for Submitting a Responsive LOI

    Find out what PCORI looks for in a letter of intent (LOI) along with other helpful tips.

    PCORI Awardee Resources

    These resources can help awardees in complying with the terms and conditions of their contract.

  • Meetings & Events
    Close mega-menu

    Meetings & Events

    • Upcoming
    • Past Events

    PCORI 2021 and Beyond

    During this webinar, PCORI leaders shared ways to get involved in PCOR, improvements to our funding opportunities, and more.

    2020 PCORI Annual Meeting

    Watch recordings of sessions and view titles and descriptions of posters presented at the virtual meeting.

    PCORI Board of Governors Meeting: April 13, 1:00pm ET

    Tune in as the Board discusses possible topics in the development of upcoming PCORI Funding Announcements, among other business. Register now.

You are here

  • Research & Results
  • Explore Our Portfolio
  • Comparing Broad- and Narrow-Spectrum ...

This project has results

Comparing Broad- and Narrow-Spectrum Antibiotics for Children with Ear, Sinus, and Throat Infections

Sign Up for Updates to This Study  

Results Summary and Professional Abstract

Results Summary
Download Summary Español (pdf) Audio Recording (mp3)

Results Summary

What was the research about?

Antibiotics are the most commonly prescribed medicine in children. Narrow-spectrum antibiotics target a few types of bacteria. Broad-spectrum antibiotics target many types of bacteria. Both types work well to treat infections. But using broad-spectrum antibiotics when they’re not needed can create antibiotic-resistant bacteria that are hard to treat. They may also have side effects, such as diarrhea or rash.

In this study, the research team compared narrow-spectrum and broad-spectrum antibiotics to treat ear, sinus, and throat infections in children.

What were the results?

  • Treating infections. Narrow-spectrum antibiotics worked as well as broad-spectrum antibiotics to treat infections. Symptoms improved the same amount in three days.
  • Side effects. Children who took narrow-spectrum antibiotics had fewer side effects than those who took broad-spectrum antibiotics.
  • Quality of life. There were no differences in quality of life between children who took broad- or narrow-spectrum antibiotics.

What did the research team do?

The research team did two studies. In both studies, children were ages 6 months to 12 years.

In the first, the research team looked at health records for 30,159 children who used broad- or narrow-spectrum antibiotics to treat ear, sinus, or throat infections. Of the children, 63 percent were white, 16 percent were mixed or another race, 12 percent were black, and 8 percent were Hispanic. The average age was 5, and 52 percent were boys. The team looked at how often treatment worked and whether patients had side effects in the month after diagnosis.

The second study included 2,472 children. All children had an ear, sinus, or throat infection. The research team interviewed parents and children about quality of life, how long symptoms lasted, and side effects after the children got antibiotics. Of the children, 59 percent were white, 23 percent were black, 8 percent were another race, and 9 percent were Hispanic. The average age was 5, and 52 percent were boys. All were patients at one of 31 children’s clinics in Pennsylvania or New Jersey.

Children, parents, and physicians helped plan and conduct the study.

What were the limits of the study?

Some children in the study may have had infections caused by viruses. Because antibiotics don’t treat viruses, the results could differ if only children with infections caused by bacteria were in the study.

Future research could study the two types of antibiotics in children with confirmed infections caused by bacteria.

How can people use the results?

Doctors and parents can use these results to make decisions about the type of antibiotic to use.

Professional Abstract

Professional Abstract

Objective

To compare the relative effectiveness of narrow- and broad-spectrum antibiotics in treating acute respiratory tract infections (ARTIs) in children

Study Design

Design Elements Description
Design Observational: cohort study
Population Retrospective cohort: 30,159 children ages 6 months to 12 years with ARTIs

Prospective cohort: 2,472 children ages 6 months to 12 years with ARTIs
Interventions/
Comparators
  • Narrow-spectrum antibiotics
  • Broad-spectrum antibiotics
Outcomes Retrospective cohort: treatment failure (primary), occurrence of side effects up to 30 days after diagnosis

Prospective cohort: quality of life (primary), presence of symptoms beyond 72 hours of treatment, occurrence of side effects
Timeframe Retrospective cohort: 30-day follow-up for primary outcome

Prospective cohort: 20-day follow-up for primary outcome

Two observational cohort studies compared the effect of broad- and narrow-spectrum antibiotics on treatment failure, quality of life, and occurrence of side effects in children ages 6 months to 12 years with ARTIs, including acute otitis media, Group A streptococcal pharyngitis, and acute sinusitis.

For the retrospective study, researchers examined electronic health records for 30,159 children with ARTIs to determine the rate of treatment failure and side effects up to 30 days after diagnosis. Among children in the retrospective cohort, 63% were white, 16% were mixed or another race, 12% were black, and 8% were Hispanic. The average age was 5, and 52% were male.

For the prospective study, researchers enrolled 2,472 children ages 6 months to 12 years with ARTIs from 31 pediatric primary care practices in Pennsylvania and New Jersey. Among children in the prospective study, 59% were while, 23% were black, 8% were another race, and 9% were Hispanic. The average age was 5, and 52% were male. Researchers interviewed parents and children about quality of life, persistence of symptoms, and side effects.

Children, parents, and physicians helped plan and conduct the study.

Results

  • Treatment failure rates: The rate of treatment failure was no different between children taking narrow- or broad-spectrum antibiotics.
  • Symptom resolution: At 72 hours after diagnosis, the rate of symptom resolution was no different between children taking narrow- or broad-spectrum antibiotics.
  • Side effects: The risk of side effects, including diarrhea, candidiasis, allergic reaction, and vomiting was significantly lower for children taking narrow-spectrum antibiotics compared with children taking broad-spectrum antibiotics (p<0.001).
  • Quality of life. Narrow-spectrum antibiotics were associated with a higher health-related quality of life that was statistically (p=0.008) but not clinically different from broad-spectrum antibiotics.

Limitations

Some children may have had viral infections, which may limit the ability to detect between-group differences.

Conclusions and Relevance

Broad-spectrum antibiotics are not more effective than narrow-spectrum antibiotics in treating pediatric ARTIs. Narrow-spectrum antibiotics were associated with a lower risk of side effects.

Future Research Needs

Future research could restrict the study sample to children with confirmed bacterial infections.

Related PCORI Dissemination and Implementation Project

Broad Implementation of Outpatient Stewardship (BIOS) Study

Final Research Report

View this project's final research report.

Journal Articles

Results of This Project

JAMA

Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections

Related Articles

Journal of the Pediatric Infectious Diseases Society

What Parents Think About the Risks and Benefits of Antibiotics for Their Child's Acute Respiratory Tract Infection

More on this Project  

PCORI Stories

Choosing the Right Antibiotic for a Child's Respiratory Infection
A narrative on this study, which compares the outcomes of treatment with targeted versus broader-spectrum bacteria-killing medications.

Videos

Choosing between Antibiotics for Acute Respiratory Tract Infections (ARTIs) in Children
Study Principal Investigator Jeffrey Gerber, MD, PhD, discusses what the findings of his study might suggest for clinicians and families in terms of the benefits and the risks of arrow- or broad-spectrum antibiotics for children with ARTIs.

Evidence Updates

Narrow- versus Broad-Spectrum Antibiotics for Common Infections in Children
When bacteria cause an ear, nose, or throat infection in children, a clinician may prescribe narrow- or broad-spectrum antibiotics. A PCORI-funded research study found a greater risk of side effects with broad-spectrum antibiotics, with no difference in symptom resolution between the two types.

Peer-Review Summary

Peer review of PCORI-funded research helps make sure the report presents complete, balanced, and useful information about the research. It also confirms that the research has followed PCORI’s Methodology Standards. During peer review, experts who were not members of the research team read a draft report of the research. These experts may include a scientist focused on the research topic, a specialist in research methods, a patient or caregiver, and a healthcare professional. Reviewers do not have conflicts of interest with the study.

The peer reviewers point out where the draft report may need revision. For example, they may suggest ways to improve how the research team analyzed its results or reported its conclusions. Learn more about PCORI’s peer-review process here.

In response to peer review, the PI made changes including

  • Adding details about the sensitivity analyses that the author conducted, as these were mentioned in the Methodology Standards checklist but initially not described in the text of the report.
  • Addressing reviewer questions about whether the statistically significant difference found on the PedsQL (pediatric quality of life measure) was clinically meaningful. The researchers added cautions about interpreting the results from this measure because the measure was not originally designed to assess child quality of life following acute respiratory infection, and because the small differences between patients treated with narrow- and broad-spectrum antibiotics were unlikely to be clinically meaningful.
  • Noting an additional limitation of the study: the analyses did not account for baseline PedsQL measures and any chronic conditions.
  • Explaining that the sampling strategies were different for the patient-centered outcomes cohort and the clinician-centered outcomes cohort. This was because the researchers stratified the recruitment of patients for patient-centered outcomes cohort by diagnosis and antibiotic type, and oversampled certain strata to insure adequate numbers to conduct analyses. This was unnecessary for the inclusion of clinicians in the clinician-centered outcomes cohort.

Conflict of Interest Disclosures

View the COI disclosure form.

Project Details

Principal Investigator
Jeffrey Gerber, MD, PhD
Project Status
Completed; PCORI Public and Professional Abstracts, and Final Research Report Posted
Project Title
Comparative Effectiveness of Broad- versus Narrow-Spectrum Antibiotics for Acute Respiratory Tract Infections in Children
Board Approval Date
September 2013
Project End Date
June 2018
Organization
The Children's Hospital of Philadelphia
Year Awarded
2013
State
Pennsylvania
Year Completed
2018
Project Type
Research Project
Health Conditions  
Infectious Diseases
Respiratory Diseases
Respiratory Infections
Intervention Strategies
Drug Interventions
Populations
Children -- 18 and under
Low Income
Racial/Ethnic Minorities
Urban
Funding Announcement
Assessment of Prevention, Diagnosis, and Treatment Options
Project Budget
$1,860,173
DOI - Digital Object Identifier
10.25302/8.2018.CE.13047279
Study Registration Information
HSRP20143536
NCT02297815
Page Last Updated: 
December 2, 2020

About Us

  • Our Programs
  • Governance
  • Financials and Reports
  • Procurement Opportunities
  • Our Staff
  • Our Vision & Mission
  • Contact Us

Research & Results

  • Explore Our Portfolio
  • Research Fundamentals
  • Research Results Highlights
  • Putting Evidence to Work
  • Peer Review
  • Evidence Synthesis
  • About Our Research

Engagement

  • The Value of Engagement
  • Engagement in Health Research Literature Explorer
  • Influencing the Culture of Research
  • Engagement Awards
  • Engagement Resources
  • Engage with Us

Funding Opportunities

  • What & Who We Fund
  • What You Need to Know to Apply
  • Applicant Training
  • Merit Review
  • Awardee Resources
  • Help Center

Meetings & Events

April 12
Engagement Awards 2021 Special Cycle -- Applicant Office Hours (Three)
April 13
Board of Governors Meeting: April 13, 2021
April 19
Increasing Vaccine Confidence among Long-Term Care Workers: Expedited COVID-19 PFA -- Applicant Town Hall

PCORI

Footer contact address

Patient-Centered Outcomes
Research Institute

1828 L Street, NW, Suite 900
Washington, DC 20036
Phone: (202) 827-7700 | Fax: (202) 355-9558
info@pcori.org

Subscribe to Newsletter

Twitter Facebook LinkedIn Vimeo

© 2011-2021 Patient-Centered Outcomes Research Institute. All Rights Reserved.

Privacy Policy | Terms of Use | Trademark Usage Guidelines | Credits | Help Center